Medications

New cell-based immunotherapy offered for melanoma

Siteman Cancer Center, based at Barnes-Jewish Hospital and Washington University School of Medicine in St. Louis, is one of the first centers nationwide to offer a newly approved cell-based immunotherapy that targets melanoma.

Oncology & Cancer

Immune cell receptor provides promising immunotherapy target

Drugs that target a receptor on immune cells called activin receptor 1C may combat tumor-induced immune suppression and help patients' immune systems fight back against cancer, according to a study by investigators at the ...

Medical research

Hyperbaric oxygen therapy tested for post-COVID conditions

Hyperbaric oxygen therapy—giving patients 100% oxygen at a pressure corresponding to 10–20 meters below sea level—has been around for almost 100 years. But the method lacks modern evidence from clinical studies, which ...

page 36 from 40